Back to Journals » OncoTargets and Therapy » Volume 9

Original Research

hERG1 positivity and Glut-1 negativity identifies high-risk TNM stage I and II colorectal cancer patients, regardless of adjuvant chemotherapy

       
Total article views   HTML views PDF downloads Totals
7,345 Dovepress* 6,866+ 1,358 8,224
PubMed Central* 479 163 642
Totals 7,345 1,521 8,866
*Since 14 October 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed and Google Scholar